(Q70796199)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8525270%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

title

Long term follow-up and patterns of response of ALT in patients with chronic hepatitis NANB/C treated with recombinant interferon-alpha (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8525270%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

author name string

L C da Silva

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8525270%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

S K Ono

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8525270%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

L E Fonseca

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8525270%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

F J Carrilho

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8525270%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

L C Mendes

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8525270%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

A V França

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8525270%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

C L Madruga

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8525270%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

A A Laudanna

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8525270%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

publication date

1 May 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8525270%20AND%20SRC:MED&resulttype=core&format=json

Revista do Instituto de Medicina Tropical de São Paulo

14 October 2019

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8525270%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8525270%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8525270%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

page(s)

239-243

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8525270%20AND%20SRC:MED&resulttype=core&format=json

Treatment with interferon(s) of community-acquired chronic hepatitis and cirrhosis type C. The TVVH Study Group.

14 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46651995000300010

Hepatitis C virus infection and disease. Diagnostic problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46651995000300010

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46651995000300010

Randomized controlled trial of recombinant alpha-2a-interferon for chronic hepatitis C. Comparison of alanine aminotransferase normalization versus loss of HCV RNA and anti-HCV IgM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46651995000300010

Lack of Protective Immunity Against Reinfection with Hepatitis C Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46651995000300010

Antiviral therapy of hepatitis C--present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46651995000300010

Treatment of chronic hepatitis C with high-dose interferon alpha-2b. A multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46651995000300010

Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Le Groupe Français pour l'Etude du Traitement des Hépatites Chroniques NANB/C

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46651995000300010

Neutralizing antibodies to recombinant alpha-interferon and response to therapy in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46651995000300010

Hepatitis C virus serotype II responds more favorably to interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46651995000300010

Autoimmune chronic hepatitis exacerbated by alpha-interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46651995000300010

Hepatitis C virus genotypes in France: comparison of clinical features of patients infected with HCV type I and type II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46651995000300010

Factors predictive of the response to interferon in patients with chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46651995000300010

Long-term surveillance of HIV, HBV, and HCV infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46651995000300010

Response to interferon alpha therapy is influenced by the iron content of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46651995000300010

10.1590/S0036-46651995000300010

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8525270%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

1 reference